ANAVEX LIFE SCIENCES CORP. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $513.27K, a 40.98% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $869.61K.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $998.80K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-06-30 | $513.27K 10-Q · filed 2022-08-09 | |
| 2021-06-30 | $869.61K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $998.80K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |